ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #4,898Hybrid

Journal of Global Antimicrobial Resistance

Acronym:jgar
•
Abbreviation (ISO):J. GLOBAL ANTIMICROB. RESIST
•
Identifier (ISSN):2213-7165(Print)/2213-7173(Online)
•
Publisher:Elsevier BV
Clarivate IF (2026)
3.7↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Global Antimicrobial Resistance

WoS Q2
13462.0220182.4720192.7120204.0420214.3520224.620233.720243.220253.72026
Annual Impact Factor Metric
Current (2026):3.7
Scopus SJR & RankScopus Q2
1.002
#4,898

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
60

60 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate5.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
218articles/year
99.68% Gold OA•97.18% Original Research

Aims & Scope

The Journal of Global Antimicrobial Resistance (JGAR) is a quarterly online journal run by an international Editorial Board that focuses on the global spread of antibiotic-resistant microbes. JGAR is a dedicated journal for all professionals working in research, health care, the environment and animal infection control, aiming to track the resistance threat worldwide and provides a single voice devoted to antimicrobial resistance (AMR). Featuring peer-reviewed and up to date research articles, reviews, short notes and hot topics JGAR covers the key topics related to antibacterial, antiviral, antifungal and antiparasitic resistance.

Topics Covered (Recognized by AI)
Biology96%Genetics92.4%Chemistry89.5%Biochemistry88.3%Microbiology88.2%Antibiotics68.9%Geology68.1%Paleontology67.8%Bacteria66.6%Medicine63.2%Gene61.6%Escherichia coli41.9%Organic chemistry37.2%Antimicrobial33.6%Antibiotic resistance33.3%Internal medicine29.4%Pathology23.5%DNA21.6%Drug resistance20.5%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

INFECTIOUS DISEASES

Q2
Rank44/141
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank120/356
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q2
Rank39/141
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank91/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.7
Articles / Year168
Total Citations42
2025
IF3.2
Articles / Year274
Total Citations786
2024
IF3.7
Articles / Year467
Total Citations1,648
2023
IF4.6
Articles / Year234
Total Citations2,053
2022
IF4.349
Articles / Year366
Total Citations3,423

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,898Scopus Q2SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
1.002

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.27

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,267 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,256
3-Year Documents695
Citable Documents537

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
MicrobiologyQ2
Microbiology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Global Antimicrobial Resistance (acronym: jgar, abbr: J. GLOBAL ANTIMICROB. RESIST, ISSN: 2213-7165) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by Elsevier BV in England. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.002 (Q2), an H-index of 60.

The journal enforces rigorous peer evaluation with an annual output of approximately 218 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,267 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier BV
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6d9f0d84-990d-4fb0-86bf-011002fd2d36
Database Updated: 2026-10-16